| pubmed-article:16438033 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16438033 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
| pubmed-article:16438033 | lifeskim:mentions | umls-concept:C0220781 | lld:lifeskim |
| pubmed-article:16438033 | lifeskim:mentions | umls-concept:C1883254 | lld:lifeskim |
| pubmed-article:16438033 | lifeskim:mentions | umls-concept:C0243072 | lld:lifeskim |
| pubmed-article:16438033 | pubmed:issue | 10-12 | lld:pubmed |
| pubmed-article:16438033 | pubmed:dateCreated | 2006-1-27 | lld:pubmed |
| pubmed-article:16438033 | pubmed:abstractText | A number of 1- or 6-substituted N9,5'-cyclo-3-(beta-ribofuranosyl)-8-azapurin-2-one derivatives were synthesized in multi-step reactions. Their anti-hepatitis C virus activities were evaluated and some structure-activity relationship is discussed. | lld:pubmed |
| pubmed-article:16438033 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16438033 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16438033 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16438033 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16438033 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16438033 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16438033 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16438033 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16438033 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16438033 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16438033 | pubmed:issn | 1525-7770 | lld:pubmed |
| pubmed-article:16438033 | pubmed:author | pubmed-author:SchinaziRaymo... | lld:pubmed |
| pubmed-article:16438033 | pubmed:author | pubmed-author:WatanabeKyoic... | lld:pubmed |
| pubmed-article:16438033 | pubmed:author | pubmed-author:OttoMichael... | lld:pubmed |
| pubmed-article:16438033 | pubmed:author | pubmed-author:StuyverLieven... | lld:pubmed |
| pubmed-article:16438033 | pubmed:author | pubmed-author:HassanAbdalla... | lld:pubmed |
| pubmed-article:16438033 | pubmed:author | pubmed-author:WangPeiyuanP | lld:pubmed |
| pubmed-article:16438033 | pubmed:author | pubmed-author:McBrayerTamar... | lld:pubmed |
| pubmed-article:16438033 | pubmed:author | pubmed-author:TharnishPhili... | lld:pubmed |
| pubmed-article:16438033 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16438033 | pubmed:volume | 24 | lld:pubmed |
| pubmed-article:16438033 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16438033 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16438033 | pubmed:pagination | 1531-42 | lld:pubmed |
| pubmed-article:16438033 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:16438033 | pubmed:meshHeading | pubmed-meshheading:16438033... | lld:pubmed |
| pubmed-article:16438033 | pubmed:meshHeading | pubmed-meshheading:16438033... | lld:pubmed |
| pubmed-article:16438033 | pubmed:meshHeading | pubmed-meshheading:16438033... | lld:pubmed |
| pubmed-article:16438033 | pubmed:meshHeading | pubmed-meshheading:16438033... | lld:pubmed |
| pubmed-article:16438033 | pubmed:meshHeading | pubmed-meshheading:16438033... | lld:pubmed |
| pubmed-article:16438033 | pubmed:meshHeading | pubmed-meshheading:16438033... | lld:pubmed |
| pubmed-article:16438033 | pubmed:meshHeading | pubmed-meshheading:16438033... | lld:pubmed |
| pubmed-article:16438033 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:16438033 | pubmed:articleTitle | Synthesis and anti-HCV activity of N9,5'-cyclo-3-(beta-D-ribofuranosyl)-8-azapurin-2-one derivatives. | lld:pubmed |
| pubmed-article:16438033 | pubmed:affiliation | Pharmasset Inc., Tucker, Georgia 30084, USA. | lld:pubmed |
| pubmed-article:16438033 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16438033 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
